Royalty Pharma's milestone payment to Arrowhead; Abeona's $75M offering
Plus, news about Soleno, Novo Nordisk and Cardior Pharmaceuticals: Royalty Pharma pays Arrowhead Pharmaceuticals: The $50 million milestone payment comes after the completed enrollment of a Phase 3 trial investigating …